Supervised Antidepressant Tapering and Deprescribing in North Carolina

Are you thinking about coming off your antidepressant?

I help adults across North Carolina taper off Effexor, Lexapro, Zoloft, Paxil, Prozac, Cymbalta, Wellbutrin, Celexa, Pristiq, Trintellix, Remeron, and trazodone. I’m a board-certified adult and forensic psychiatrist. I use hyperbolic tapers, where the steps get smaller as your dose gets lower.

After more than a few months on an antidepressant, a short taper, such as half the dose for 2 weeks, shows little benefit over stopping abruptly (Horowitz and Taylor 2019). The withdrawal that follows can look like the original condition coming back.

• You see me at every visit, from the first evaluation to the last dose.
• I’m a DO, licensed in North Carolina.
• I see patients by video anywhere in North Carolina, and in person at my Wilmington office by request.
• $250 a month covers up to four visits. I don’t bill insurance for my monthly practice.
• I supervise tapers for antidepressants, benzodiazepines, sleep medications, and gabapentinoids.

Book a free 15-minute consultation or call (910) 612-6015.

What Deprescribing Means

Deprescribing is the planned, supervised reduction of a medication, with the goal of stopping it or reaching the lowest dose that still does its job. That can mean one antidepressant taken for 9 years.

In practice, deprescribing means a taper with a physician watching. That physician knows the pharmacology, adjusts the pace when symptoms show up, and can tell withdrawal from relapse.

---

Who This Service Is For

• You’ve been on an antidepressant for years and want to find out whether you still need it.
• You tried to stop once or more and got hit by antidepressant discontinuation syndrome, with symptoms such as brain zaps, dizziness, insomnia, and flu-like aches.
• You take more than one psychiatric medication and want a plan for the whole list.
• You started an antidepressant taper with another prescriber and want me to take it over.
• You take a benzodiazepine or a sleep medication long-term and want off, safely.
• You take gabapentin or pregabalin and want to reduce.

This isn’t an emergency service. If you’re in crisis now, call or text 988.

High-dose benzodiazepine dependence sometimes needs more support than outpatient telehealth can give. I’ll tell you on the first call if that’s you.

---

How a Supervised Taper Works

1. 01EvaluationYour drug, your dose, how long you’ve taken it, and what happened when you tried to stop before.
2. 02The planHyperbolic steps sized to your current dose, with a liquid form for the small final steps when the drug has one on its FDA label.
3. 03One step downA small cut from the dose you take now.
4. 04Check in with meI review your symptoms and sort withdrawal from relapse.
5. If you’re stableTake the next stepOne more small cut.Back to 03
   If symptoms show upHold or slow downYou stay at this dose until you settle.Then back to 03
6. 05The last stepsThe smallest and slowest cuts, because each milligram has its largest effect near the bottom of the dose range.
7. 06FinishOff the drug, or on the lowest dose that still works for you.

The plan. I use hyperbolic tapering: each reduction is a percentage of your current dose. Fixed milligram cuts get harsher the lower you go. For SSRIs and SNRIs, each milligram has a bigger effect on the serotonin transporter near the bottom, so my steps shrink as the dose drops (Horowitz and Taylor 2019).

NICE guidance in the UK takes the same approach. Each step is a proportion of the previous dose, drugs with a short half-life come down more slowly, and a liquid form is worth considering once tablets can’t make the small steps (NICE NG222).

Dose Time

• Hyperbolic steps
• Equal cuts

The check-ins. You check in, I look at your symptoms, and I hold the dose, slow down, or take the next step. Withdrawal versus relapse is the central clinical call. Withdrawal usually shows up within days of a dose change (Fava 2015), while depression that appears later points more toward relapse (Kalfas 2025).

---

The Antidepressants I Taper

Every antidepressant comes off differently. Two facts shape most of the difficulty: how fast the drug leaves your body (its half-life), and whether it comes in a form that allows small final steps, such as a liquid.

SNRIs and paroxetine carry a higher risk of withdrawal than most other antidepressants (Horowitz 2023).

Brand	Generic	Half-life	Liquid form
Effexor XR	venlafaxine	about 5 hours (11 for its active metabolite)	No
Pristiq	desvenlafaxine	about 11 hours	No
Cymbalta	duloxetine	about 12 hours	No
Paxil	paroxetine	about 21 hours	Yes, oral suspension
Wellbutrin SR, XL	bupropion	about 21 hours	No
Zoloft	sertraline	about 26 hours	Yes, oral solution
Lexapro	escitalopram	about 27 to 32 hours	Yes, generic oral solution
Remeron	mirtazapine	about 20 to 40 hours	No
Celexa	citalopram	about 35 hours	Yes, generic oral solution
Trintellix	vortioxetine	about 66 hours	No
Prozac	fluoxetine	4 to 6 days with long-term use	Yes, generic oral solution

Effexor XR (Venlafaxine)

Venlafaxine has the shortest half-life on this list, and levels fall within hours of a missed or reduced dose. The FDA label says some people need several months to come off it. In a systematic review, withdrawal appeared most common with venlafaxine among the SNRIs (Fava 2018).

The label says not to divide the XR capsule, and there’s no FDA-labeled liquid, so I plan the final steps with you before the first cut. My guide on how to taper off Effexor goes into the details.

Pristiq (Desvenlafaxine)

Desvenlafaxine is the active metabolite of venlafaxine, and it shares the short half-life. A 2024 meta-analysis placed it among the antidepressants with more frequent withdrawal symptoms (Henssler 2024), and the label reports discontinuation symptoms that “can be protracted and severe.”

The extended-release tablet has to be swallowed whole, so I plan the small final steps early, as with Effexor. My guide on how to taper off Pristiq covers its half-life, dose forms and withdrawal timeline.

Cymbalta (Duloxetine)

The Cymbalta label says not to open the capsule, because that can damage its coating. The half-life is also short, about 12 hours, so I plan the low end of the taper with the most care.

I explain why the capsule shapes the whole plan in how to taper off Cymbalta.

Paxil (Paroxetine)

Paroxetine’s metabolites have almost no activity, so the level of active drug falls quickly when the dose drops. In a randomized trial that interrupted treatment, it caused more discontinuation symptoms than fluoxetine or sertraline (Rosenbaum 1998), and NICE names it, with venlafaxine, as needing particular care (NICE NG222).

The Paxil label includes an oral suspension, which helps with the small final steps. My guide on how to taper off Paxil has more.

Prozac (Fluoxetine)

Fluoxetine is usually the easiest antidepressant on this list to stop. With long-term use, its half-life is 4 to 6 days, and its active metabolite lasts 4 to 16 days, so levels fall gradually on their own.

The label says the long half-life may minimize discontinuation symptoms, and it still recommends a gradual reduction. A generic oral solution makes small steps simple. See how to taper off Prozac.

Zoloft (Sertraline)

Sertraline sits in the middle of the range, with a half-life of about 26 hours. Its main metabolite lasts longer, but the label calls it substantially less active, so it probably does little to ease withdrawal.

Zoloft comes as an oral solution that allows small steps. It contains alcohol and has to be diluted. My Zoloft withdrawal guide has more.

Lexapro (Escitalopram)

Studies disagree on how often escitalopram causes withdrawal. A 2024 meta-analysis put it in the higher-frequency group (Henssler 2024), and a head-to-head trial found fewer symptoms than with paroxetine (Baldwin 2006). I taper it as carefully as the others.

A generic escitalopram oral solution has an FDA label, which helps with small final steps. My guide on how to taper off Lexapro covers its half-life, dose forms and withdrawal timeline.

Celexa (Citalopram)

The 20 mg and 40 mg tablets are scored, and a generic oral solution has an FDA label. The prescribing information recommends a gradual reduction whenever possible.

I haven’t found comparative withdrawal data strong enough to rank it, so I set the pace by how you respond.

Wellbutrin (Bupropion)

Bupropion acts on dopamine and norepinephrine. Its half-life is about 21 hours, and its active metabolites last about 20 to 37 hours. The SR and XL tablets can’t be crushed or split, which limits small steps.

The label has no discontinuation-syndrome warning section. Withdrawal after stopping it has still been reported (Berigan 1999), and I haven’t found controlled studies comparing it with other antidepressants.

Trintellix (Vortioxetine)

The Trintellix label says it can be stopped abruptly. Its long half-life, about 66 hours, is part of the reason. The same label reports headache and muscle tension after stopping the higher doses and suggests stepping down from those first.

In company-sponsored trials, symptoms after stopping were similar to placebo (Baldwin 2016). Those trials lasted 6 to 8 weeks, so they say little about years of use.

Remeron (Mirtazapine)

The Remeron label lists a discontinuation syndrome, including dizziness, abnormal dreams, and electric-shock sensations, and recommends a gradual reduction. It comes in small and scored tablet strengths, and there’s no FDA-labeled liquid.

I also taper trazodone. If brain zaps stopped your last attempt with any of these drugs, tell me at your evaluation, and I’ll pace the plan around that history.

---

Benzodiazepines, Sleep Medications, and Gabapentinoids

Benzodiazepines and sleep medications. These tapers go slower, and the pace matters more. The Xanax (alprazolam) label warns that stopping suddenly or cutting the dose fast after continued use may cause withdrawal reactions that can be life-threatening (FDA label).

International guidance on deprescribing these drugs now exists, and the common thread is gradual reduction with support (Brandt 2024). Expect the taper to take months.

Gabapentinoids. Gabapentin and pregabalin get less attention, and the evidence on deprescribing them is still thin: a 2023 review found only 4 studies (Anderson 2023). I use the same gradual, monitored approach here.

---

Why Tapers Fail

Tapers usually fail for 1 of 3 reasons.

Linear cuts. A common schedule is half, then a quarter, then stop. The final “small” cut is the largest change in effect on the serotonin transporter. Hyperbolic pacing is built around this, and it comes from brain-imaging data (Horowitz and Taylor 2019).

Speed. A 2-week taper after 2 years of use carries a real risk of withdrawal. Longer use raises it: in a 2025 primary care survey, more than 2 years on the drug carried roughly 10 times the odds of a withdrawal syndrome compared with under 6 months (Horowitz 2025). The survey had a low response rate, so treat the exact figure with caution.

Misread symptoms. Withdrawal can look like relapse, and people sometimes restart drugs they didn’t need to restart.

The honest base rates: about 31% of people stopping an antidepressant report at least one discontinuation symptom, versus 17% of people stopping a placebo, with severe symptoms at 2.8% versus 0.6% (Henssler 2024). An older review put the weighted average at 56%, across 14 studies with very different methods (Davies and Read 2019). The typical case runs 1 to 2 weeks (Warner 2006).

A 2025 meta-analysis found that stopping an antidepressant was not associated with worsening depression scores (Kalfas 2025). Withdrawal is real. It’s also usually manageable when the taper is slow enough for the drug.

---

What It Costs

One flat fee: $250 a month covers up to four visits, including your evaluation, plus messaging between visits. I answer messages within 1 to 2 business days. A careful taper takes months, and the flat fee keeps the cost predictable the whole way.

I don’t bill insurance for my monthly practice. Labs and medications are paid separately.

Ongoing psychiatric care beyond the taper is covered by the same fee; see psychiatry services.

The fee also covers every dose adjustment. Book a free 15-minute consultation to start.

---

What to Expect Over Time

Here’s what I promise: a plan built on the pharmacology, pacing set by how you respond, and a straight answer if I think stopping is the wrong move right now.

Some symptoms are possible even with a careful taper, and they can last for weeks (Fava 2015). In a 2025 survey, about 20% of people reported withdrawal symptoms lasting more than 3 months (Horowitz 2025), and longer cases have been described in an online case series (Hengartner 2020). Brain zaps and protracted withdrawal are real, and I’ve written about both.

---

Frequently Asked Questions About Tapering in North Carolina

Which antidepressants do you taper?

I taper Effexor (venlafaxine), Pristiq (desvenlafaxine), Cymbalta (duloxetine), Paxil (paroxetine), Prozac (fluoxetine), Zoloft (sertraline), Lexapro (escitalopram), Celexa (citalopram), Wellbutrin (bupropion), Trintellix (vortioxetine), Remeron (mirtazapine), and trazodone.

Can you take over an antidepressant taper another prescriber started?

Yes. Bring your current dose, the steps you’ve taken so far, and how each one went. I review that history with you and plan the next step from where you are.

Can you taper me off a drug I’ve taken for 10 years or more?

Yes, I can plan and supervise that taper. Long duration raises the odds of withdrawal, and it mostly means the taper runs slower.

Will I get withdrawal symptoms?

Possibly, even with a careful taper. The realistic goal is to keep symptoms mild and brief.

How long will my taper take?

Most antidepressant tapers take months. Benzodiazepine tapers take longer, and so does any taper after a rough withdrawal history. I can give you a realistic estimate after your evaluation.

Do you prescribe the medication during the taper?

Yes. I manage the drug through the whole taper, including the low doses at the end. Some tapers use an FDA-labeled liquid for the final steps.

Do you take insurance?

I don’t bill insurance for my monthly practice.

Is this telehealth only?

I see patients by video anywhere in North Carolina, and in person at my Wilmington office by request. For a video visit, you need to be physically located in North Carolina at the time of the visit.

---

This page is educational and does not create a physician-patient relationship. Do not stop or change a psychiatric medication without speaking to your prescriber. Tapering decisions require individualized clinical assessment. The diagrams show the general shape of a taper and are not a dosing schedule. If you are in crisis, call or text 988.

References (18)

1. Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019. PMID: 30850328.
2. National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222), recommendations 1.4.16 and 1.4.18. 2022. NICE NG222.
3. Fava GA, et al. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom. 2015. PMID: 25721705.
4. Kalfas M, et al. Incidence and nature of antidepressant discontinuation symptoms: a systematic review and meta-analysis. JAMA Psychiatry. 2025. PMID: 40632531.
5. Horowitz MA, et al. Estimating risk of antidepressant withdrawal from a review of published data. CNS Drugs. 2023. PMID: 36513909.
6. US Food and Drug Administration. Prescribing information on DailyMed, accessed October 2026: Xanax (benzodiazepine boxed warning); Effexor XR; Pristiq; desvenlafaxine extended-release; Cymbalta; Paxil; Prozac; fluoxetine oral solution; Zoloft; Lexapro; escitalopram oral solution; Celexa; citalopram oral solution; Wellbutrin XL; Wellbutrin SR; Trintellix; Remeron.
7. Fava GA, et al. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom. 2018. PMID: 30016772.
8. Henssler J, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024. PMID: 38851198.
9. Rosenbaum JF, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998. PMID: 9646889.
10. Baldwin DS, et al. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int Clin Psychopharmacol. 2006. PMID: 16528138.
11. Berigan TR, Harazin JS. Bupropion-associated withdrawal symptoms: a case report. Prim Care Companion J Clin Psychiatry. 1999. PMID: 15014696.
12. Baldwin DS, et al. The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies. J Psychopharmacol. 2016. PMID: 26864543.
13. Brandt J, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. 2024. PMID: 38516102.
14. Anderson PA, et al. Deprescribing interventions for gabapentinoids in adults: a scoping review. Br J Clin Pharmacol. 2023. PMID: 37221314.
15. Horowitz MA, et al. Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services. Psychiatry Res. 2025. PMID: 40404538.
16. Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav. 2019. PMID: 30292574.
17. Warner CH, et al. Antidepressant discontinuation syndrome. Am Fam Physician. 2006. PMID: 16913164.
18. Hengartner MP, et al. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol. 2020. PMID: 33489088.